These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 730356)
1. Formation of antibody to matrix protein in experimental human influenza A virus infections. Cretescu L; Beare AS; Schild GC Infect Immun; 1978 Nov; 22(2):322-7. PubMed ID: 730356 [TBL] [Abstract][Full Text] [Related]
2. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. Oxford JS; Schild GC; Potter CW; Jennings R J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040 [TBL] [Abstract][Full Text] [Related]
3. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers. Desheva YA; Smolonogina TA; Donina SA; Rudenko LG BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924 [TBL] [Abstract][Full Text] [Related]
4. Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. Al-Khayatt R; Jennings R; Potter CW J Hyg (Lond); 1984 Oct; 93(2):301-12. PubMed ID: 6389697 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. Snyder MH; Clements ML; Betts RF; Dolin R; Buckler-White AJ; Tierney EL; Murphy BR J Clin Microbiol; 1986 May; 23(5):852-7. PubMed ID: 3711273 [TBL] [Abstract][Full Text] [Related]
7. Antigenic memory to influenza A viruses in man determined by monovalent vaccines. Marine WM; Thomas JE Postgrad Med J; 1979 Feb; 55(640):98-104. PubMed ID: 461278 [TBL] [Abstract][Full Text] [Related]
8. Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses. Tamura M; Webster RG; Ennis FA J Virol; 1994 Jun; 68(6):3499-504. PubMed ID: 8189489 [TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge. Fries LF; Dillon SB; Hildreth JE; Karron RA; Funkhouser AW; Friedman CJ; Jones CS; Culleton VG; Clements ML J Infect Dis; 1993 Mar; 167(3):593-601. PubMed ID: 8440931 [TBL] [Abstract][Full Text] [Related]
10. Reversed single-radial-immunodiffusion test: the method for the assay of the antibody to influenza A nucleoprotein. Yamane N; Odagiri T; Arikawa J; Ishida N Tohoku J Exp Med; 1981 Mar; 133(3):245-55. PubMed ID: 6797098 [TBL] [Abstract][Full Text] [Related]
11. Production of human monoclonal antibody to X31 influenza virus nucleoprotein. Crawford DH; Callard RE; Muggeridge MI; Mitchell DM; Zanders ED; Beverley PC J Gen Virol; 1983 Mar; 64 Pt 3():697-700. PubMed ID: 6298350 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of live attenuated influenza A/Scotland/74 (H3N2) virus vaccine against challenge with influenza A/Victoria/3/75 (H3N2) virus. Betts RF; Douglas RG; Roth FK; little JW J Infect Dis; 1977 Dec; 136(6):746-53. PubMed ID: 925382 [TBL] [Abstract][Full Text] [Related]
13. Application of the single radial diffusion test for assay of antibody to influenza type A viruses. Mostow SR; Schild GC; Dowdle WR; Wood RJ J Clin Microbiol; 1975 Dec; 2(6):531-40. PubMed ID: 812886 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the single radial hemolysis test for measuring hemagglutinin- and neuraminidase-specific antibodies to H3N2 influenza strains and antibodies to influenza B. Farrohi K; Farrohi FK; Noble GR; Kaye HS; Kendal AP J Clin Microbiol; 1977 Mar; 5(3):353-60. PubMed ID: 323281 [TBL] [Abstract][Full Text] [Related]
15. The M protein of influenza viruses has no immunizing effect. Becht H; Gruschkau H; Rott R Med Microbiol Immunol; 1979; 167(4):285-8. PubMed ID: 545115 [TBL] [Abstract][Full Text] [Related]
16. Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers. Yamane N; Nakamura Y; Yuki M; Odagiri T; Ishida N J Hyg (Lond); 1984 Apr; 92(2):231-42. PubMed ID: 6707472 [TBL] [Abstract][Full Text] [Related]
17. [Basic characteristics of a live influenza vaccine for children from type A influenza (H1N1 and H3N2) used separately and in combination]. Rudenko LG; Shvartsman IaS; Ispolatova AV; Grigor'eva EP; Drinevskiĭ VP Vopr Virusol; 1989; 34(1):29-34. PubMed ID: 2728404 [TBL] [Abstract][Full Text] [Related]
18. Anti M-protein antibody response to type A or B natural influenza detected by solid phase enzyme linked immunosorbent assay and by complement fixation. Joassin L; Reginster M; Vaira D Arch Virol; 1983; 76(1):15-23. PubMed ID: 6860147 [TBL] [Abstract][Full Text] [Related]
20. Interference following dual inoculation with influenza A (H3N2) and (H1N1) viruses in ferrets and volunteers. Potter CW; Jennings R; Clark A; Ali M J Med Virol; 1983; 11(1):77-86. PubMed ID: 6834013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]